This disclosure is a regulatory filing submitted to BSE Limited and Metropolitan Stock Exchange of India Limited, providing an updated outcome of the Board Meeting held on 04.07.2026. The original filing dated 04.07.2026 had inadvertently omitted the appointment of Mr. Satyanarayana Murthy Varanasi as an Additional Director.

The Board of Directors met on Saturday, 04.07.2026 at 3:00 p.m. at the Registered Office of the Company at 6-3-354/13/B2, Suryateja Apartments, Hindinagar, Punjagutta, Hyderabad - 500082, Telangana. The meeting concluded at 4:10 p.m.

The following matters were considered and approved:

1. Appointment of Additional Director (Professional)

  • Mr. Ravi Kanth Naga Pattabhi Chopperla (DIN: 06812649) was appointed as an Additional Director in the category of Professional and Non-Executive, effective 04.07.2026.
  • This appointment is subject to the approval of the shareholders of the Company.
  • Mr. Chopperla holds 16,16,001 Equity shares (7.1%) in the company.
  • His profile indicates he is a seasoned business leader and fundraising professional with over 18 years of experience in investor relations, corporate advisory, business transformation, and financial services. He currently serves as Executive Director & Chief Operating Officer of QROPS Advisory Services (QAS) Private Limited and as a Non-Executive Director of ECI Systems Private Limited. He is a Certified Independent Director.

2. Scheme of Reduction of Capital

  • The Board approved a Proposal for a Scheme of Reduction of Capital under Section 66 read with Section 52 and other applicable provisions of the Companies Act, 2013.
  • The Scheme provides for the reduction and re-organisation of the capital of the Company.
  • It contemplates the cancellation and extinguishment of 11,37,48,550 (Eleven crores thirty-seven lakhs forty-eight thousand five hundred fifty) fully paid-up equity shares of ₹10 each on a pro-rata basis.
  • The purpose is to realign the equity capital structure to better reflect the current capital base and to set off past year(s) accumulated losses.
  • The quantitative effect is a reduction of the Company's paid-up equity share capital from ₹22,74,97,100 (2,27,49,710 equity shares) to ₹11,37,48,550 (1,13,74,855 equity shares).
  • An amount of ₹11,37,48,550 will be set off against the total accumulated losses and share premium balance (totalling ₹11,57,66,110).
  • The shareholding pattern post-reduction will be adjusted so that the percentage shareholding of each existing shareholder remains unchanged. No consideration will be paid to shareholders for the cancelled shares.
  • No benefit will accrue to the promoter/promoter group/group companies from this restructuring.
  • The Scheme is subject to necessary approvals from shareholders, the Hyderabad Bench of the National Company Law Tribunal (NCLT), and other statutory/regulatory approvals.
  • BSE Limited has been nominated as the Designated Stock Exchange for the purpose of the Scheme.
  • The Scheme will be made available on the company's website after filing with the stock exchanges.

3. Alteration of Memorandum of Association

  • The Board approved the alteration of the Main Object Clause of the Memorandum of Association by inserting a new sub-clause 5.
  • The new object is: "To carry on the business of pet animal healthcare and wellness, including establishing, operating, managing and providing veterinary, diagnostic, preventive, curative, therapeutic, rehabilitation, grooming, nutrition, wellness and allied services for pet and companion animals; and to manufacture, formulate, develop, purchase, sell, distribute, import, export and otherwise deal in veterinary medicines, pharmaceuticals, nutraceuticals, pet foods, animal healthcare products, medical devices, grooming products, accessories and all other products and services related to pet animal healthcare, wellness and animal welfare."
  • This alteration is subject to the approval of the shareholders by way of a Special Resolution and other required approvals.

4. Related Party Transactions

  • The Board approved a proposal for entering into Related Party Transactions with QROPS Advisory Services Private Limited, an Associate Company.
  • This is subject to the approval of the shareholders in accordance with the Companies Act, 2013 and SEBI LODR Regulations, 2015.

5. Directors Report and AGM Notice

  • The Board approved the Directors Report for the Financial Year 2025-26.
  • The Board approved the notice for convening the Annual General Meeting (AGM) for FY 2025-26.

6. Annual General Meeting Schedule

  • The AGM for FY 2025-26 is scheduled to be held on Monday, 10th August 2026 at 11:00 A.M.
  • The meeting will be conducted through Video Conference or Other Audio-Visual Means (OAVM).

7. Cut-off Date for AGM

  • The cut-off date for determining members entitled to vote at the AGM shall be Monday, 3rd August 2026.

8. Appointment of Additional Director (Independent)

  • Mr. Satyanarayana Murthy Varanasi (DIN: 11121911) was appointed as an Additional Director in the Independent category, effective 04.07.2026.
  • The term of appointment is for 5 years, subject to the approval of the shareholders.
  • Mr. Varanasi holds 1,14,430 Equity shares (0.50%) in the company.
  • His profile indicates he has experience in defence, aviation, maritime operations, legal practice, and management consulting. He has served in the Indian Navy, Indian Airlines/Air India, Visakhapatnam Port Trust, and the Merchant Navy. He is presently practicing as an Advocate before the High Court of Telangana and is registered with the Independent Directors Databank.

This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.